Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CREX - US22530J3095 - Common Stock

2.64 USD
-0.02 (-0.75%)
Last: 12/29/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, CREX scores 3 out of 10 in our fundamental rating. CREX was compared to 95 industry peers in the Media industry. Both the profitability and financial health of CREX have multiple concerns. CREX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CREX had positive earnings in the past year.
CREX had a negative operating cash flow in the past year.
In multiple years CREX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.93%, CREX is doing worse than 70.53% of the companies in the same industry.
With a Return On Equity value of -41.80%, CREX is not doing good in the industry: 62.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of CREX (43.13%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CREX has grown nicely.
CREX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
The number of shares outstanding for CREX has been increased compared to 5 years ago.
Compared to 1 year ago, CREX has a worse debt to assets ratio.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.52, we must say that CREX is in the distress zone and has some risk of bankruptcy.
CREX's Altman-Z score of -0.52 is on the low side compared to the rest of the industry. CREX is outperformed by 71.58% of its industry peers.
A Debt/Equity ratio of 1.01 is on the high side and indicates that CREX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.01, CREX is in line with its industry, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC7.27%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.03 indicates that CREX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.03, CREX is in line with its industry, outperforming 43.16% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that CREX may have some problems paying its short term obligations.
CREX's Quick ratio of 0.77 is on the low side compared to the rest of the industry. CREX is outperformed by 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

CREX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, CREX shows a very negative growth in Revenue. The Revenue has decreased by -18.37% in the last year.
CREX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.98% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.98% on average per year.
Based on estimates for the next years, CREX will show a very strong growth in Revenue. The Revenue will grow by 32.68% on average per year.
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.86, which indicates a rather expensive current valuation of CREX.
Based on the Price/Earnings ratio, CREX is valued a bit cheaper than 71.58% of the companies in the same industry.
When comparing the Price/Earnings ratio of CREX to the average of the S&P500 Index (26.84), we can say CREX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 10.15, the valuation of CREX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 71.58% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.40. CREX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.86
Fwd PE 10.15
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CREX is valued a bit more expensive than 66.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 101.5
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's earnings are expected to grow with 66.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CREATIVE REALITIES INC

NASDAQ:CREX (12/29/2025, 8:00:00 PM)

2.64

-0.02 (-0.75%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners15.19%
Inst Owner Change-23.71%
Ins Owners17.24%
Ins Owner Change21.85%
Market Cap27.77M
Revenue(TTM)44.32M
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (214.02%)
Short Float %0.83%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)13.04%
PT rev (3m)22.64%
EPS NQ rev (1m)-519.92%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)-724.39%
EPS NY rev (3m)-633.33%
Revenue NQ rev (1m)15.57%
Revenue NQ rev (3m)41.39%
Revenue NY rev (1m)12.01%
Revenue NY rev (3m)6.38%
Valuation
Industry RankSector Rank
PE 18.86
Fwd PE 10.15
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB N/A
EV/EBITDA 101.5
EPS(TTM)0.14
EY5.3%
EPS(NY)0.26
Fwd EY9.85%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS4.21
BVpS2.08
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.56
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z -0.52
F-Score2
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to decline by -97.82% in the next year.